European Leukemia Trial Registry
Trial: ONO 1910

More Details
Title Randomized Study of ON 01910.Na in Refractory MDS With Excess Blasts
Scientific Title Phase III MultiCenter Randomized Controlled Study to Assess Efficacy and Safety of ON 01910.Na 72-Hr Continuous IV Infusion in MDS Patients With Excess Blasts Relapsing After or Refractory to or Intolerant to Azacitidine or Decitabine
Short Title ONO 1910
Trialgroup NN
Type of Trial multicentric, randomized, open-label
Disease Myelodysplastic Syndrome(MDS) Intermedia II and high risk
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.11.2010
Contactperson

Principal Investigator
Platzbecker, Prof. Dr. med., Uwe
Tel: +49 (0)351 4582583
Fax: +49 (0)351 458-5362
Email: Uwe.Platzbecker@uniklinikum-dresden.de

Shortprotocol Shortprotocol
created 10.01.2012 Johannes Kraus
changed 29.10.2013 Sina Hehn
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org